» Articles » PMID: 24593777

Cancer Trends in Lebanon: a Review of Incidence Rates for the Period of 2003-2008 and Projections Until 2018

Overview
Publisher Biomed Central
Specialty Public Health
Date 2014 Mar 6
PMID 24593777
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The analysis of cancer incidence trends is essential to health care planning. The aim of this study is to examine variations in cancer incidence rates in Lebanon between 2003 and 2008 and use the observed trends to project cancer incidence until 2018.

Methods: Using secondary data with a cumulative caseload of 45,753 patients from the National Cancer Registry database of the Ministry of Public Health in Lebanon, we estimated sex- and site- specific incidence of cancer for each year of the six-year period between 2003 and 2008. Logarithmic regressions were fitted to estimate the cancer incidence for the forecast years until 2018.

Results: Between 2003 and 2008, males and females presented with an overall 4.5% and 5.4% annual increase, respectively. Significant increases were observed for cancers of the liver and prostate among males, and for cancers of the liver, thyroid, and corpus uteri among females. By 2018, incidence rates were projected to approach 296.0 and 339.5 cases per 100,000 for males and females, respectively. The most common five types of cancer are expected to be prostate, bladder, lung, non-Hodgkin, and colon among males; and breast, ovarian, non-Hodgkin, lung, and colon among females.

Conclusion: The increased availability of screening programs and a growing smoking epidemic, most notably in women, are the most likely explanations behind the increased cancer incidence in the past decade. An aging population and higher proportion of older people suggest further increases in the cancer caseload in the future. The health care system in Lebanon will be required to adapt to the growing burden of cancer in our population.

Citing Articles

Pediatric and adolescent cancer disparities in the Middle East and North Africa (MENA) region: incidence, mortality, and survival across socioeconomic strata.

Shukla A, Zeidan R, Saddik B BMC Public Health. 2024; 24(1):3602.

PMID: 39736554 PMC: 11684239. DOI: 10.1186/s12889-024-21155-8.


Unlocking Early Cancer Detection: Exploring Biomarkers, Circulating DNA, and Innovative Technological Approaches.

Prasanth B, Alkhowaiter S, Sawarkar G, Dharshini B, R Baskaran A Cureus. 2024; 15(12):e51090.

PMID: 38274938 PMC: 10808885. DOI: 10.7759/cureus.51090.


Esophageal cancer: a twenty-four-year experience at a tertiary care center with an evaluation of the prognostic significance of the neutrophil-lymphocyte ratio.

Mahmoud W, Hassoun L, Kerbage A, Mukherji D, Shamseddine A, Tamraz S BMC Gastroenterol. 2024; 24(1):27.

PMID: 38195445 PMC: 10775605. DOI: 10.1186/s12876-023-03115-5.


Cancer Incidence and Mortality Estimates in Arab Countries in 2018: A GLOBOCAN Data Analysis.

Al-Muftah M, Al-Ejeh F Cancer Epidemiol Biomarkers Prev. 2023; 32(12):1738-1746.

PMID: 37733340 PMC: 10690144. DOI: 10.1158/1055-9965.EPI-23-0520.


The association between angiotensin receptor blockers and lung, bladder, and colon cancer development: A 10-year multicentric retrospective Lebanese study.

Dagher Y, El Helou S, Haifa K, Chalhoub I, Boulos R, Atallah B Medicine (Baltimore). 2023; 102(36):e34901.

PMID: 37682163 PMC: 10489396. DOI: 10.1097/MD.0000000000034901.


References
1.
El Saghir N, Khalil M, Eid T, El Kinge A, Charafeddine M, Geara F . Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis. Int J Surg. 2007; 5(4):225-33. DOI: 10.1016/j.ijsu.2006.06.015. View

2.
Dyba T, Hakulinen T . Comparison of different approaches to incidence prediction based on simple interpolation techniques. Stat Med. 2000; 19(13):1741-52. DOI: 10.1002/1097-0258(20000715)19:13<1741::aid-sim496>3.0.co;2-o. View

3.
ABOU-DAOUD K . Morbidity from cancer in Lebanon. Cancer. 1966; 19(9):1293-300. DOI: 10.1002/1097-0142(196609)19:9<1293::aid-cncr2820190917>3.0.co;2-l. View

4.
King W, Marrett L . Case-control study of bladder cancer and chlorination by-products in treated water (Ontario, Canada). Cancer Causes Control. 1996; 7(6):596-604. DOI: 10.1007/BF00051702. View

5.
Sibai A, Nasreddine L, Mokdad A, Adra N, Tabet M, Hwalla N . Nutrition transition and cardiovascular disease risk factors in Middle East and North Africa countries: reviewing the evidence. Ann Nutr Metab. 2010; 57(3-4):193-203. DOI: 10.1159/000321527. View